165 AZD2171, a potent VEGF receptor tyrosine kinase inhibitor, combined with mechanistically distinct antitumor therapies in vivo
| Autor: | Wedge, S., Kendrew, J., Valentine, P.J., Brave, S.R., Barnett, S., Jurgensmeier, J.M., Hennequin, L.F., Ogilvie, D.J. |
|---|---|
| Zdroj: | In EJC Supplements 2004 2(8):52-52 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect